Overview

A Study of IMR-687 in Healthy Adult Volunteers

Status:
Completed

Trial end date:
2017-07-08

Target enrollment:

Participant gender:

Summary

The purpose of this Phase 1a, first in human, randomized, double-blind, placebo-controlled study is to evaluate the safety, tolerability, PK and PD profile of the orally administered IMR-687 in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Imara, Inc.

Collaborator:

Quintiles, Inc.